Public log · Verified July 2026
Changelog
22 dated entries across 12 of the 16 platforms we track, newest first. Every score change, price correction and roster move is here with the reasoning as it was written on the day. Comparison sites in this category move rankings without saying so, which is the whole reason this page exists.
Entries are never rewritten. When we get something wrong, the fix lands as a new entry with a new date and the original stays where it is, including the ranks and wing sizes it quoted at the time. 6of the platforms below pay us a commission and their corrections publish the same way as everyone else's. Who pays us.
How often prices get re-checked
5 providers a week, longest-unverified first, so the full roster of 16 comes round about every 4weeks. Each pass re-reads the provider's own published pricing page, updates the verification date, and promotes a reported figure to verified only when it was seen directly. Providers that block automated readers stay on reported labels until someone checks them by hand, and we say which ones those are on the editorial policy page.
August 20261 entry
- Aug 1
Search Console access went liveSite
The site's Google Search Console property became readable to our tooling, so position and impression data now informs which pages get worked on. Before this, page selection ran on keyword-tool estimates and guesswork about what was already ranking.
July 202616 entries
- Jul 31
AlloyProvider
Restored to the live roster. Alloy was parked on 2026-07-07 for having no Katalys program, which left the A-F transparency scale with no A on it. Every published price re-read on myalloy.com/solutions this day and unchanged: estradiol pill $39.99/mo, patch $74.99/mo, gel $69.99/mo, Evamist spray $69.99/mo, vaginal cream $119.97 per 3-month supply, progesterone from $23/mo, paroxetine $34.99/mo. The $49 one-time consult fee is still [Reported]. Alloy earns us no commission.
- Jul 31
Alloy restored to the rosterSite
Alloy came back after being parked on 2026-07-07 for having no affiliate program, which had left the Transparency Grade scale with no A on it at all. Its comparison page was still indexed and still getting impressions while returning a 404. Every published price was re-read the same day and none had moved. Alloy earns us nothing.
- Jul 27
Elektra Health added to the women's wingSite
A new entry rather than a restore. Elektra bills commercial insurance and charges per visit rather than monthly, which is one of the reasons the price column now carries an explicit disclosure type instead of a bare number.
- Jul 27
Midi Health, Defy Medical and Gennev restoredSite
Three providers parked on 2026-07-07 came back. All three price per visit or publish only an average, and rendering any of them as a monthly rate would have been a false comparison, so the price field gained a disclosure type in the same pass: monthly, per visit, average only, insurance, or not published.
- Jul 24
WispProvider
Added to the women's wing at 7.3 (rank 5 of 8), Transparency B. Wisp discloses its own pricing better than anything else below rank 3, publishing a flat $99 consult with no intake gate, and it is the only provider here dispensing FDA-approved hormones through your local pharmacy where insurance applies. First drafted at the wing floor (6.8, rank 8) on the reasoning that the $99 excludes the medication and no labs are required before systemic hormones. Recomputing the evidence overruled that: Wisp scores a strict 4.6, the third-strongest floor in the wing, against Gala 2.8, Hers 2.7, Telos 2.5 and Inner Balance 1.4, so floor placement would have ranked a 4.6-evidence provider below a 1.4. Held below Hers (7.4) because Hers's $79 includes the hormones. Ranks 6 through 8 each shifted down one. Provisional; four disclosure criteria and the entire review picture are unverified this pass, so re-rank after a deeper crawl. New Katalys affiliate partner; the evidence moved it up, not the partnership.
- Jul 8
MangoRxProvider
Added to the men's wing at 7.0 (rank 3 within wing, tied with PeterMD by score), Transparency C: a genuinely all-inclusive $99/mo injectable TRT with labs included and public-company (NASDAQ: MGRX) corporate disclosure earn the highest strict base of the three men-only providers, but the broad-platform positioning (TRT is one line on a GLP-1/ED/hair menu, not a TRT specialty), a tiny platform-wide review base, and a JS-blocked funnel hold it to the 7.0 floor, below Hone (7.5). Scoped to the men's wing. Provisional (new to us). New Katalys affiliate partner; affiliate status does not move the score.
- Jul 7
Gala HealthProvider
Added to the women's wing at 7.2 (rank 4), Transparency C: a public $79/mo cash-pay price and a multi-format compounded menu earn a mid-tier score, held down by unnamed clinicians, undisclosed compounded status on its own funnel, a platform-wide (non-menopause) review base, and a press-release reputation pattern. Provisional (new to us, landing JS-blocked, <25 independently-verifiable menopause reviews). First live Katalys affiliate partner; affiliate status does not move the score.
- Jul 7
Sesame CareProvider
Added to the women's wing at 7.6 (rank 2), Transparency B: the only provider here that prescribes FDA-approved generic hormones (filled at your own pharmacy on insurance) from named, credentialed clinicians, with upfront public pricing, earning the highest strictly-evidenced base in the set. Held below Winona (8.4) by the marketplace trade-offs: menopause is one of 120+ services, no specialist continuity, care depth varies, no menopause-specific review base, and a minority of surprise-charge complaints. Provisional (new to us, no menopause-line review base). New Katalys affiliate partner; affiliate status does not move the score.
- Jul 7
Telos RXProvider
Added to the women's wing at 6.9 (rank 7, the wing floor), Transparency D: a broad, peptide-led telehealth platform where menopause HRT is one line on a wide menu, not a specialty. Labs-based dosing is a plus, but the HRT-specific price is not published (only GLP-1 and peptide prices appear), the hormones are compounded and not FDA-approved, no clinicians are named, and no independent menopause review base exists. Scoped to the women's wing only (TRT not a confirmed product). Provisional (new to us). New Katalys affiliate partner; affiliate status does not move the score.
- Jul 6
AlloyProvider
Consult fee corrected $35 to $49. Entry price corrected to $39.99/mo (estradiol pill, verified on /solutions). Added compounded-med state exclusions, 3-month billing reality, Trustpilot/BBB data. Promoted to #1: only full-pricing-pre-intake provider in the set (Transparency A).
- Jul 6
Hers MenopauseProvider
Score 8.1 → 7.4. Entry price corrected $49 → $79/mo (12-month-plan anchor, per company materials); Trustpilot 3.4 platform-wide added; intake-gated pricing + unnamed clinicians graded Transparency D; marked provisional (line launched late 2025).
- Jul 6
Hone HealthProvider
Score 7.6 → 7.5, wing set to 'both'. Two-part pricing verified on homepage ($25/$155 membership + meds, old $89 estimate replaced); $65 assessment added; Trustpilot 4.8 × 10k+ and BBB A+ accredited confirmed; two-part cost opacity graded Transparency C.
- Jul 6
Inner BalanceProvider
Score 7.4 → 7.0. July pass could not verify pricing or clinical claims; no independent review base; graded Transparency D and marked provisional.
- Jul 6
MaximusProvider
Added to men's wing at 6.5 (rank 6 within wing): strongest enclomiphene/oral-TRT protocol menu, scored under the BBB-F cap (≤7.0) with additional deductions for anchor pricing and crawler-blocked verification (Transparency D).
- Jul 6
PeterMDProvider
Added to men's wing at 7.0 (rank 4 within wing): cheapest all-in injectable TRT, capped by the BBB fulfillment/refund complaint pattern and crawl-blocked unverifiable pricing (Transparency C).
- Jul 6
WinonaProvider
Score 8.6 → 8.4. Entry price corrected $119 → $54/mo (estrogen tablets, verified on product page); full price menu added. Review base updated to ~6,000 Trustpilot at 4.7. Text-only care and zero corporate disclosure weighed against the verified $0-consult pricing (Transparency B).
May 20265 entries
- May 12
AlloyProvider
Initial verification: $35 consult, price 75/mo entry.
- May 12
Hers MenopauseProvider
Initial entry: $49/mo estimate, bundled-platform framing.
- May 12
Hone HealthProvider
Initial verification: $89/mo entry estimate, coed platform.
- May 12
Inner BalanceProvider
Initial entry at 7.4.
- May 12
WinonaProvider
Initial verification: $119/mo entry, per-cycle billing noted.
What is missing from this log
4 of the 16platforms carry no entries yet. That means nothing has changed on their record since they landed, and it is worth reading as exactly that rather than as a clean bill of health. The women's wing currently holds 13 platforms and the men's wing 5, and the review pages carry the per-fact verification dates that this page summarises.
This is general information, not medical advice. A score change here is an editorial judgment about a platform, and it carries no clinical meaning. Corrections go to the address on our about page and publish as a new dated entry.
Midi Health
Sesame Care